Weight Loss

Tirzepatide

Dual GLP-1 / GIP

Dual GLP-1 / GIP receptor agonist β€” the next generation of incretin research compounds.

Vial10mg
MW4813.5 Da
Common research dose2500 mcg
$219.99

Checkout launches soon β€” tap Add to Cart to join the waitlist. Run reconstitution calculator β†’

About Tirzepatide

Dual GLP-1 / GIP receptor agonist β€” the next generation of incretin research compounds. Also known as Dual GLP-1 / GIP.

Tirzepatide is supplied as a lyophilized powder in a 10mg vial. Commonly referenced research protocols reconstitute with 2ml of bacteriostatic water, yielding a concentration of 5000 mcg/ml.

Reconstitution reference

Using 2ml bacteriostatic water in a 10mg vial produces 5000 mcg/ml. A 2500mcg research dose = 50.0 IU on a U-100 insulin syringe.

Open calculator with Tirzepatide preloaded

Related peptides

Semaglutide

GLP-1 Agonist

Long-acting GLP-1 receptor agonist widely studied for metabolic and appetite research.

5mg vial $149.99
Trending

Retatrutide

Triple Agonist (GLP-1/GIP/Glucagon)

Next-generation triple receptor agonist β€” the most talked-about research peptide of 2026.

10mg vial $279.99

Research Use Only. All products sold are for laboratory research purposes only. Not for human consumption, diagnostic use, or therapeutic use. Must be 21+ to purchase.